Moderate additive immunosuppressive effect of thalidomide combined with cyclosporin A in rat cardiac transplantation
halidomide is an immunomodulating agent shown to prolong graft survival in experimental skin, renal, cardiac and bone marrow transplantation. The main purpose of the present study was to investigate the possible additive effect of combining thalidomide with cyclosporin A (CyA). Members of our group have previously created a bsis for such studies by demonstrating the ability of Linomide to abolish
